logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

ASCO 2020 – New regimen yields better adherence, less toxicity in head and neck SCC

First hints of noninferiority for chemoradiotherapy weekly vs q3w in high-risk, post-op patients.